{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T08:06:45Z","timestamp":1774598805808,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,21]],"date-time":"2019-04-21T00:00:00Z","timestamp":1555804800000},"content-version":"am","delay-in-days":385,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["R01 LM 010685"],"award-info":[{"award-number":["R01 LM 010685"]}]},{"name":"NIH","award":["P50 GM115305"],"award-info":[{"award-number":["P50 GM115305"]}]},{"name":"NCATS\/NIH","award":["ULTR000445"],"award-info":[{"award-number":["ULTR000445"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.phrs.2018.02.013","type":"journal-article","created":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T13:01:13Z","timestamp":1518440473000},"page":"44-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Calcium channel blockers as drug repurposing candidates for gestational diabetes: Mining large scale genomic and electronic health records data to repurpose medications"],"prefix":"10.1016","volume":"130","author":[{"given":"Jeffery A.","family":"Goldstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa A.","family":"Bastarache","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua C.","family":"Denny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan M.","family":"Roden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill M.","family":"Pulley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Aronoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.phrs.2018.02.013_bib0005","doi-asserted-by":"crossref","first-page":"e97871","DOI":"10.1371\/journal.pone.0097871","article-title":"Gestational diabetes mellitus in Africa: a systematic review","volume":"9","author":"Macaulay","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.phrs.2018.02.013_bib0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11892-015-0699-x","article-title":"Prevalence of gestational diabetes and risk of progression to type 2 diabetes: a global perspective","volume":"16","author":"Zhu","year":"2016","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.phrs.2018.02.013_bib0015","series-title":"Diabetes in Pregnancy: Management of Diabetes and Its Complications from Preconception to the Postnatal Period","author":"National Collaborating Centre for Women\u2019s and Children\u2019s Health (UK)","year":"2008"},{"issue":"6","key":"10.1016\/j.phrs.2018.02.013_bib0020","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/1753-0407.12422","article-title":"GESTATIONAL DIABETES MELLITUS: current knowledge and unmet needs","volume":"8","author":"Koning","year":"2016","journal-title":"J Diabetes"},{"issue":"19","key":"10.1016\/j.phrs.2018.02.013_bib0025","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","article-title":"Hyperglycemia and adverse pregnancy outcomes","volume":"358","author":"HAPO Study Cooperative Research Group","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.phrs.2018.02.013_bib0030","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2337\/dc15-0433","article-title":"Gestational diabetes mellitus in early pregnancy: evidence for poor pregnancy outcomes despite treatment","volume":"39","author":"Sweeting","year":"2016","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.phrs.2018.02.013_bib0035","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/14767050903550659","article-title":"The fetal and maternal consequences of gestational diabetes mellitus","volume":"23","author":"Reece","year":"2010","journal-title":"J. Matern-Fetal Neonatal. Med."},{"issue":"14","key":"10.1016\/j.phrs.2018.02.013_bib0040","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1056\/NEJMoa0902430","article-title":"A multicenter, randomized trial of treatment for mild gestational diabetes","volume":"361","author":"Landon","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.phrs.2018.02.013_bib0045","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2337\/dc14-2159","article-title":"Mild gestational diabetes mellitus and long-term child health","volume":"38","author":"Landon","year":"2015","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.phrs.2018.02.013_bib0050","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1210\/jc.2008-0772","article-title":"Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions","volume":"93","author":"Ratner","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.phrs.2018.02.013_bib0055","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/GCO.0000000000000127","article-title":"Interventions to modify the progression to type 2 diabetes mellitus in women with gestational diabetes: a systematic review of literature","volume":"26","author":"Morton","year":"2014","journal-title":"Curr. Opin. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.phrs.2018.02.013_bib0060","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1586\/eog.10.29","article-title":"Drug development for use during pregnancy: impact of the placenta","volume":"5","author":"Malek","year":"2010","journal-title":"Expert Rev. Obstet. Gynecol."},{"key":"10.1016\/j.phrs.2018.02.013_bib0065","series-title":"Family Medicine Obstetrics","first-page":"676","article-title":"Drugs for common conditions in pregnancy","year":"2008"},{"key":"10.1016\/j.phrs.2018.02.013_bib0070","series-title":"Tarascon Pocket Pharmacopoeia","author":"Hamilton","year":"2012"},{"key":"10.1016\/j.phrs.2018.02.013_bib0075","unstructured":"Prescribing medicines in pregnancy database | Therapeutic Goods Administration (TGA). https:\/\/www.tga.gov.au\/prescribing-medicines-pregnancy-database. (Accessed May 14 2016)."},{"key":"10.1016\/j.phrs.2018.02.013_bib0080","unstructured":"Research C for DE and Labeling \u2013 Pregnancy and Lactation Labeling (Drugs) Final Rule. https:\/\/www.fda.gov\/Drugs\/DevelopmentApprovalProcess\/DevelopmentResources\/Labeling\/ucm093307.htm. (Accessed March 29 2017)."},{"issue":"9","key":"10.1016\/j.phrs.2018.02.013_bib0085","first-page":"1205","article-title":"PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations","volume":"26","author":"Denny","year":"2010","journal-title":"Bioinf. Oxf. Engl."},{"issue":"3","key":"10.1016\/j.phrs.2018.02.013_bib0090","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/clpt.2008.89","article-title":"Development of a large-scale de-identified DNA biobank to enable personalized medicine","volume":"84","author":"Roden","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2018.02.013_bib0095","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1752-8062.2010.00175.x","article-title":"Principles of human subjects protections applied in an opt-out, de-identified biobank","volume":"3","author":"Pulley","year":"2010","journal-title":"Clin. Transl. Sci."},{"issue":"234","key":"10.1016\/j.phrs.2018.02.013_bib0100","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008604","article-title":"Biobanks and electronic medical records: enabling cost-effective research","volume":"6","author":"Bowton","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.phrs.2018.02.013_bib0105","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses","volume":"81","author":"Purcell","year":"2007","journal-title":"Am. J. Hum. Genet."},{"issue":"12","key":"10.1016\/j.phrs.2018.02.013_bib0110","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/nbt.2749","article-title":"Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data","volume":"31","author":"Denny","year":"2013","journal-title":"Nat. Biotechnol."},{"issue":"24","key":"10.1016\/j.phrs.2018.02.013_bib0115","first-page":"2938","article-title":"SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap","volume":"24","author":"Johnson","year":"2008","journal-title":"Bioinf. Oxf. Engl."},{"issue":"9","key":"10.1016\/j.phrs.2018.02.013_bib0120","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.tig.2014.07.004","article-title":"Functional and genomic context in pathway analysis of GWAS data","volume":"30","author":"Mooney","year":"2014","journal-title":"Trends Genet TIG"},{"issue":"7","key":"10.1016\/j.phrs.2018.02.013_bib0125","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ajmg.b.32328","article-title":"Gene set analysis: a step-by-step guide","volume":"168","author":"Mooney","year":"2015","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet."},{"issue":"1","key":"10.1016\/j.phrs.2018.02.013_bib0130","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/hmg\/ddl438","article-title":"Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs","volume":"16","author":"Saccone","year":"2007","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.phrs.2018.02.013_bib0135","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1365-3016.2000.00228.x","article-title":"Maternal obesity and glucose intolerance during pregnancy among Mexican-Americans","volume":"14","author":"Kieffer","year":"2000","journal-title":"Paediatr. Perinat. Epidemiol."},{"issue":"2","key":"10.1016\/j.phrs.2018.02.013_bib0140","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0301-2115(00)00548-0","article-title":"Calcium channel blockers in the management of preterm labor and hypertension in pregnancy","volume":"97","author":"Papatsonis","year":"2001","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"1","key":"10.1016\/j.phrs.2018.02.013_bib0145","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/uog.14836","article-title":"Hemodynamic effects of intravenous nicardipine in severely pre-eclamptic women with a hypertensive crisis","volume":"47","author":"Cornette","year":"2016","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"11","key":"10.1016\/j.phrs.2018.02.013_bib0150","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0895-7061(02)03019-4","article-title":"Improvement of insulin sensitivity by a long-acting nifedipine preparation (nifedipine-CR) in patients with essential hypertension","volume":"15","author":"Koyama","year":"2002","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.phrs.2018.02.013_bib0155","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.diabres.2016.01.021","article-title":"Calcium channel blocker use is associated with lower fasting serum glucose among adults with diabetes from the REGARDS study","volume":"115","author":"Khodneva","year":"2016","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"1","key":"10.1016\/j.phrs.2018.02.013_bib0160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01.hjh.0000194119.42722.21","article-title":"New-onset diabetes and antihypertensive drugs","volume":"24","author":"Mancia","year":"2006","journal-title":"J. Hypertens."},{"issue":"9","key":"10.1016\/j.phrs.2018.02.013_bib0165","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1111\/jcmm.13096","article-title":"Comparing six antihypertensive medication classes for preventing new-onset diabetes mellitus among hypertensive patients: a network meta-analysis","volume":"21","author":"Yang","year":"2017","journal-title":"J. Cell. Mol. Med."},{"issue":"12","key":"10.1016\/j.phrs.2018.02.013_bib0170","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1111\/bph.12622","article-title":"Assessment of re-aggregated human pancreatic islets for secondary drug screening","volume":"171","author":"Ramachandran","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.phrs.2018.02.013_bib0175","doi-asserted-by":"crossref","first-page":"e47084","DOI":"10.1371\/journal.pone.0047084","article-title":"Glucose decouples intracellular Ca2+ activity from glucagon secretion in mouse pancreatic islet alpha-cells","volume":"7","author":"Le Marchand","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.phrs.2018.02.013_bib0180","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.3390\/ijms12117569","article-title":"Nifedipine protects INS-1 \u03b2-cell from high glucose-induced ER stress and apoptosis","volume":"12","author":"Wang","year":"2011","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.phrs.2018.02.013_bib0185","doi-asserted-by":"crossref","first-page":"e67498","DOI":"10.1371\/journal.pone.0067498","article-title":"Preconditioning with associated blocking of Ca2+ inflow alleviates hypoxia-induced damage to pancreatic \u03b2-cells","volume":"8","author":"Ma","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.phrs.2018.02.013_bib0190","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4093\/dmj.2016.40.2.89","article-title":"Serotonin as a new therapeutic target for diabetes mellitus and obesity","volume":"40","author":"Oh","year":"2016","journal-title":"Diabetes Metab. J."},{"issue":"1\u20133","key":"10.1016\/j.phrs.2018.02.013_bib0195","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejphar.2009.09.049","article-title":"Impact of the 5-HT3 receptor channel system for insulin secretion and interaction of ginger extracts","volume":"624","author":"Heimes","year":"2009","journal-title":"Eur. J. Pharmacol."},{"issue":"48","key":"10.1016\/j.phrs.2018.02.013_bib0200","doi-asserted-by":"crossref","first-page":"19420","DOI":"10.1073\/pnas.1310953110","article-title":"Serotonin regulates glucose-stimulated insulin secretion from pancreatic \u03b2 cells during pregnancy","volume":"110","author":"Ohara-Imaizumi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.phrs.2018.02.013_bib0205","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1210\/en.2014-1687","article-title":"Functional role of serotonin in insulin secretion in a diet-induced insulin-resistant state","volume":"156","author":"Kim","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.phrs.2018.02.013_bib0210","doi-asserted-by":"crossref","first-page":"948427","DOI":"10.1155\/2014\/948427","article-title":"Evaluation of buspirone on streptozotocin induced type 1 diabetes and its associated complications","volume":"2014","author":"Raghunathan","year":"2014","journal-title":"BioMed Res. Int."},{"issue":"15","key":"10.1016\/j.phrs.2018.02.013_bib0215","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2165\/00002018-200225150-00005","article-title":"Glucose intolerance with atypical antipsychotics","volume":"25","author":"Hedenmalm","year":"2002","journal-title":"Drug Saf."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661817310083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661817310083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:53:12Z","timestamp":1760910792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661817310083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":43,"alternative-id":["S1043661817310083"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2018.02.013","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calcium channel blockers as drug repurposing candidates for gestational diabetes: Mining large scale genomic and electronic health records data to repurpose medications","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2018.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}